Other Briefings
China’s Cosmetics and Personal Care Market: Key Trends and Business Outlook
China is now the world’s second-largest cosmetics and personal care market and leads regional growth in Asia. We delve into the key drivers building up China’s beauty and personal care sector and the business scope for foreign brands.
Understanding China’s Longevity Market: Industry Segments, Trends and Opportunities
China’s longevity market is emerging as a powerful new growth frontier as the country enters a rapidly aging demographic era. Driven by national-level policy support since 2024, China is shifting from reactive elderly care to proactive, lifespan-oriented innovation across healthcare, biotech, and smart eldercare.
China Moves Toward Absolute Emissions Cap in Carbon Trading System
China is moving toward an absolute emissions cap in its national carbon trading system, signaling a major policy shift. The new directive aims to strengthen carbon pricing and accelerate decarbonization across key industries.
China Tech Cities on the Rise: AI and VC Opportunities for Global Investors
China’s leading tech cities are gaining global prominence in AI, biotech, and smart manufacturing. This article examines the investment implications for foreign firms navigating China’s evolving innovation landscape.
Key Regulatory Developments in China’s F&B Sector: Implications for Industry Stakeholders
China’s food and beverage sector is undergoing major regulatory transformation in 2025. From dairy standards to digital labeling and health food approvals, the reforms signal a shift toward safety, transparency, and strategic market access.
Can China’s Sports and Fitness Industry Drive New Consumption?
As interest in sports and fitness grows across China, the government is harnessing the industry’s potential as a driver of new domestic consumption. We look at the latest trends, policy initiatives, and investment opportunities in the burgeoning sector.
China’s Biopharma Industry Clusters: Mapping Opportunities and Regional Strengths
China’s biopharma industry clusters form a solid base for the industry’s research, commercialization, and global integration, while offering growing opportunities for foreign firms.
Understanding China’s AI + Manufacturing Roadmap: Implications for FIEs
China’s AI + Manufacturing initiative is transforming production across sectors, enabling flexible, data-driven, and precision operations.
